Danaher To Buy G.E’s Biopharmaceutical Unit In $21.4 Billion Deal
Posted by
www.biotecnika.org
Danaher To Buy G.E's Biopharmaceutical Unit In $21.4 Billion Deal In a
drastic move take to pay down debt and stabilize the business, General
Electric(G.E) have Agreed to sell its biopharmaceutical business to
Danaher in a deal valued at $21.4 billion. The pact involves a $21
billion in cash transaction, also Danaher's assumption of certain
pension liabilities of […]
The post Danaher To Buy G.E's Biopharmaceutical Unit In $21.4 Billion
Deal appeared first on BioTecNika .
https://www.biotecnika.org/2019/02/danaher-to-buy-g-es-biopharmaceutical-unit-in-21-4-billion-deal/
Biotech News
Subscribe to:
Post Comments (Atom)
Post a Comment